IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT04849325

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04849325
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04849325. Randomized; single masking; primary purpose treatment. Start 2021-12-09 (actual); primary completion 2024-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease
Acronym
GENIUS
Condition
Critical Limb Ischemia (CLI)
Intervention (Device)
Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titan™)
Intervention (Device)
Percutaneous Transluminal Angioplasty (PTA) Device
Lead sponsor
Biotyx Medical (Shenzhen) Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct04849325
Content hash
2936013fb0e43b0e2a393330f4e0c7c0167fc2bc02c14a090828ace70536291d